University of California San Francisco
Helen Diller Family Comprehensive Cancer Center
Prostate Cancer Disparities Greatest in Low-Risk Disease

Prostate Cancer Disparities Greatest in Low-Risk Disease

December 19, 2018

Black men in the United States are known to suffer disproportionately from prostate cancer. Now, a new study investigating prostate cancer deaths by race has found that African American men have twice the chance of dying from low-risk prostate cancer than men of other racial ...
Year in Review: 2018

Year in Review: 2018

December 12, 2018

Precision medicine, immunotherapy, and population health led the news at the UCSF Helen Diller Family Comprehensive Cancer Center in 2018.  Whether through expediting drug discovery, tailoring genomic sequencing, or expanding palliative care, our UCSF cancer community remained committed to improving outcomes for every cancer ...
Cancer Researchers ID 'Achilles Heel' of Drug-Resistant Tumors

Cancer Researchers ID 'Achilles Heel' of Drug-Resistant Tumors

November 26, 2018

UC San Francisco scientists have figured out why some lung cancers become drug-resistant after initially responding to targeted therapies. In the process, they devised a new two-pronged approach that yields an effective treatment for these cancers in the laboratory and holds tremendous promise for the ...
New Method Of Breast Reconstruction May Reduce Pain For Some Cancer Survivors

New Method Of Breast Reconstruction May Reduce Pain For Some Cancer Survivors

November 20, 2018

For nearly four decades, the main option for breast reconstruction for women who had to undergo a mastectomy was to place implants under the main chest muscle – a procedure that often results in chronic pain and muscle weakness in the chest and arms. Hani ...
Small Molecule Discovery Core combines high-throughput biology and medicinal chemistry to accelerate drug discovery

Small Molecule Discovery Core combines high-throughput biology and medicinal chemistry to accelerate drug discovery

November 15, 2018

The goal of the Small Molecule Discovery Core (SMD) is to help the Cancer Center and other investigators initiate drug discovery and chemical biology projects for their most innovative and exciting new targets. Faculty co-directors Adam Renslo, PhD and Michelle Arkin, PhD, both of UCSF’s ...
New 'SLICE' Tool Can Massively Expand Immune System's Cancer-Fighting Repertoire

New 'SLICE' Tool Can Massively Expand Immune System's Cancer-Fighting Repertoire

November 15, 2018

Immunotherapy can cure some cancers that until fairly recently were considered fatal. In addition to developing drugs that boost the immune system’s cancer-fighting abilities, scientists are becoming expert at manipulating a patient’s own immune cells, turning them into cancer-killing armies. But cancers have tricks ...